Discontinuation of anti-seizure therapy in epilepsy patients

Currently, among one of the most important issues in epileptology is discontinuation of anti-seizure therapy in patients with epilepsy. The article presents contemporary approaches to solving the problem of discontinuation of antiepileptic drugs (AEDs) in patients with epilepsy based on assessing Ru...

Full description

Saved in:
Bibliographic Details
Main Authors: O. A. Milovanova, M. B. Mironov, E. A. Sandu
Format: Article
Language:Russian
Published: IRBIS LLC 2025-05-01
Series:Эпилепсия и пароксизмальные состояния
Subjects:
Online Access:https://www.epilepsia.su/jour/article/view/1191
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395648712933376
author O. A. Milovanova
M. B. Mironov
E. A. Sandu
author_facet O. A. Milovanova
M. B. Mironov
E. A. Sandu
author_sort O. A. Milovanova
collection DOAJ
description Currently, among one of the most important issues in epileptology is discontinuation of anti-seizure therapy in patients with epilepsy. The article presents contemporary approaches to solving the problem of discontinuation of antiepileptic drugs (AEDs) in patients with epilepsy based on assessing Russian and foreign publications, as well as our clinical experience. A comprehensive analysis of high-priority medical sources on AED discontinuation was carried out, including recommendations proposed by the Italian League Against Epilepsy (2013), practical recommendations for adults and children released by the American Academy of Neurology (2021) currently referenced on the official International League Against Epilepsy website, as well as recommendations of the Russian League Against Epilepsy (2022). A fundamentally crucial point in all the recommendations presented above is the lack of strict time frames, and that all provisions can be discussed with a patient and patient’s relatives. It is emphasized that a high quality of life of a patient with epilepsy is achieved only in the absence of epileptic seizures. In this regard, it seems extremely important to apply an individual approach to AED discontinuation, depending on preferences specified by a patient and patient’ family. All aspects related to AED discontinuation should be discussed by neurologists (epileptologists) in collaboration with lawyers, patient family members and various community representatives, not forgetting about the medical-social, medical-legal and ethical issues that arise upon AED discontinuation as well as decision-making on removing the diagnosis of epilepsy.
format Article
id doaj-art-7722e6c0325f4d419dae40ff8f5eab8b
institution Kabale University
issn 2077-8333
2311-4088
language Russian
publishDate 2025-05-01
publisher IRBIS LLC
record_format Article
series Эпилепсия и пароксизмальные состояния
spelling doaj-art-7722e6c0325f4d419dae40ff8f5eab8b2025-08-20T03:39:32ZrusIRBIS LLCЭпилепсия и пароксизмальные состояния2077-83332311-40882025-05-011719410010.17749/2077-8333/epi.par.con.2025.227678Discontinuation of anti-seizure therapy in epilepsy patientsO. A. Milovanova0M. B. Mironov1E. A. Sandu2Russian Medical Academy of Continuous Professional Education ; Bashlyaeva Children's City Clinical HospitalBashlyaeva Children's City Clinical Hospital ; Center for Neurology and PediatricsUniversity Clinical Hospital No. 5, Sechenov University ; Istok Clinic LLCCurrently, among one of the most important issues in epileptology is discontinuation of anti-seizure therapy in patients with epilepsy. The article presents contemporary approaches to solving the problem of discontinuation of antiepileptic drugs (AEDs) in patients with epilepsy based on assessing Russian and foreign publications, as well as our clinical experience. A comprehensive analysis of high-priority medical sources on AED discontinuation was carried out, including recommendations proposed by the Italian League Against Epilepsy (2013), practical recommendations for adults and children released by the American Academy of Neurology (2021) currently referenced on the official International League Against Epilepsy website, as well as recommendations of the Russian League Against Epilepsy (2022). A fundamentally crucial point in all the recommendations presented above is the lack of strict time frames, and that all provisions can be discussed with a patient and patient’s relatives. It is emphasized that a high quality of life of a patient with epilepsy is achieved only in the absence of epileptic seizures. In this regard, it seems extremely important to apply an individual approach to AED discontinuation, depending on preferences specified by a patient and patient’ family. All aspects related to AED discontinuation should be discussed by neurologists (epileptologists) in collaboration with lawyers, patient family members and various community representatives, not forgetting about the medical-social, medical-legal and ethical issues that arise upon AED discontinuation as well as decision-making on removing the diagnosis of epilepsy.https://www.epilepsia.su/jour/article/view/1191epilepsyanticonvulsant therapyantiepileptic drugsdiscontinuationrecommendations
spellingShingle O. A. Milovanova
M. B. Mironov
E. A. Sandu
Discontinuation of anti-seizure therapy in epilepsy patients
Эпилепсия и пароксизмальные состояния
epilepsy
anticonvulsant therapy
antiepileptic drugs
discontinuation
recommendations
title Discontinuation of anti-seizure therapy in epilepsy patients
title_full Discontinuation of anti-seizure therapy in epilepsy patients
title_fullStr Discontinuation of anti-seizure therapy in epilepsy patients
title_full_unstemmed Discontinuation of anti-seizure therapy in epilepsy patients
title_short Discontinuation of anti-seizure therapy in epilepsy patients
title_sort discontinuation of anti seizure therapy in epilepsy patients
topic epilepsy
anticonvulsant therapy
antiepileptic drugs
discontinuation
recommendations
url https://www.epilepsia.su/jour/article/view/1191
work_keys_str_mv AT oamilovanova discontinuationofantiseizuretherapyinepilepsypatients
AT mbmironov discontinuationofantiseizuretherapyinepilepsypatients
AT easandu discontinuationofantiseizuretherapyinepilepsypatients